ArticleJournal of cheminformatics2026
AdaptMol: domain adaptation for molecular image recognition with limited supervision.
Article in Journal of cheminformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Optical Chemical Structure Recognition (OCSR) aims to convert two-dimensional molecular images into machine-readable formats such as SMILES strings. Deep learning has substantially improved OCSR performance, yet most methods rely on synthetic training data and struggle to generalize to real-world inputs, especially hand-drawn diagrams, where stroke width, geometry, and drawing conventions vary widely across individuals. In this work, we propose an image-to-graph model AdaptMol that enables effective transfer from synthetic to real-world data without requiring manual graph annotations in the target domains. AdaptMol is an integrated pipeline that starts with training a base model on synthetic data, and then refines model representations through unsupervised domain adaptation and self-training. Our key insight is that bond features are domain-invariant in nature; they encode structural relationships between atoms that are independent of visual variations across domains. Thus, during domain adaptation, we align bond-level feature distributions via class-conditional Maximum Mean Discrepancy (MMD) to enforce cross-domain consistency. We also design a comprehensive data augmentation strategy to enhance the robustness of the base model, facilitating stable self-training on unlabeled target samples. On hand-drawn molecular images, our model achieves 82.6% accuracy and outperforms the best prior method by 10.7 points, while maintaining competitive performance across four benchmarks comprising molecular images from scientific literature and patent documents.Scientific contributionWe propose AdaptMol, an image-to-graph model that predicts molecular structures as graphs of atoms and bonds, achieving effective transfer from synthetic to hand-drawn molecular images without requiring target domain graph annotations. We combine class-conditional Maximum Mean Discrepancy to align bond features across domains with comprehensive data augmentation to increase training data variation, jointly improving base model accuracy sufficiently for self-training and addressing the critical failure mode of prior approaches that begin with insufficient accuracy. We further introduce a dual position representation that supervises atom positions through both discrete coordinate tokens and continuous spatial heatmaps to reduce false positives in atom localization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.